Filing Details

Accession Number:
0001179110-17-015260
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-12 16:58:14
Reporting Period:
2017-12-08
Accepted Time:
2017-12-12 16:58:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651561 Tabula Rasa Healthcare Inc. TRHC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1125761 J Michael Gausling 205 Webster Street
Bethlehem PA 18015
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-12-08 523,805 $25.85 1,390,273 No 4 S Indirect By: Originate Growth Fund #1Q, L.P.
Common Stock Disposition 2017-12-11 160,375 $25.85 1,229,898 No 4 S Indirect By: Originate Growth Fund #1Q, L.P.
Common Stock Disposition 2017-12-08 237,195 $25.85 629,594 No 4 S Indirect By: Originate Growth Fund #1A, L.P.
Common Stock Disposition 2017-12-11 72,625 $25.85 556,969 No 4 S Indirect By: Originate Growth Fund #1A, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By: Originate Growth Fund #1Q, L.P.
No 4 S Indirect By: Originate Growth Fund #1Q, L.P.
No 4 S Indirect By: Originate Growth Fund #1A, L.P.
No 4 S Indirect By: Originate Growth Fund #1A, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,000 Direct
Footnotes
  1. Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  2. Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  3. Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  4. Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
  5. The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.